4//SEC Filing
Diem Michael Craig 4
Accession 0001062993-23-002307
CIK 0001850119other
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 6:49 PM ET
Size
10.5 KB
Accession
0001062993-23-002307
Insider Transaction Report
Form 4
Diem Michael Craig
Chief Business Officer
Transactions
- Award
Common Stock
2023-02-02+21,875→ 123,238 total - Award
Stock Option (right to buy)
2023-02-02+131,250→ 131,250 totalExercise: $4.64Exp: 2033-02-02→ Common Stock (131,250 underlying) - Award
Stock Option (right to buy)
2023-02-02+131,250→ 131,250 totalExercise: $4.64Exp: 2033-02-02→ Common Stock (131,250 underlying) - Award
Common Stock
2023-02-02+21,875→ 101,363 total
Footnotes (2)
- [F1]Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Century Therapeutic, Inc.'s (the "Company's") common stock. The RSUs vest 25% on February 2, 2024 and the remaining 75% vest on a quarterly basis for the three years thereafter, in each case subject the Reporting Person's continued service through the applicable vesting date. The RSUs will be settled on each applicable vesting date in shares of the Company's common stock.
- [F2]The option vests 25% on February 2, 2024, with the remaining 75% vesting in 36 equal monthly installments, subject to the Reporting Person's continued service with the Issuer.
Issuer
Century Therapeutics, Inc.
CIK 0001850119
Entity typeother
Related Parties
1- filerCIK 0001497624
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 6:49 PM ET
- Size
- 10.5 KB